help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doglioni, C.
Right arrow Articles by Viale, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doglioni, C.
Right arrow Articles by Viale, G.

American Journal of Pathology, Vol 127, 519-529, Copyright © 1987 by American Society for Investigative Pathology

REGULAR ARTICLES

Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins

C Doglioni, P Dell'Orto, G Coggi, P Iuzzolino, L Bontempini and G Viale

Sixteen choroid plexus tumors (CPTs) have been investigated for the localization of different immunocytochemical markers of epithelial and nonepithelial nature, namely, simple epithelial-type cytokeratins, vimentin, glial fibrillary acidic protein (GFAP), a panepithelial antigen defined by the lu-5 monoclonal antibody (lu-5 antigen), S-100 protein, and epithelial membrane antigen (EMA). Intermediate filament proteins have been identified in paraffin sections of 14 of 16 cases (87.5%). In all these tumors, cytokeratins and vimentin were constantly coexpressed by the neoplastic cells, in a manner similar to that of the cells lining normal choroid plexus. In 7 of these 14 cases, in addition to cytokeratins and vimentin, the neoplastic cells were shown to coexpress GFAP, which is not synthesized by their normal cell counterpart. The appearance of GFAP immunoreactivity in CPTs might be related to an ependymal differentiation of the neoplastic cells, because normal ependyma and ependymomas constantly coexpress GFAP and vimentin. The simultaneous expression of three distinct intermediate filament proteins by the same neoplastic cells is an exceedingly rare phenomenon, which has never been reported by double labeling technique in neoplasms of the central nervous system. Despite the complex antigenic profile of the CPT, which includes immunoreactivity for lu-5 antigen, S-100 protein, and EMA in most of the cases, positivity for three different epithelial markers indicates that these tumors have an epithelial nature. Moreover, the immunocytochemical typing of CPT with the panel of antibodies used in the current investigation allows differentiation from other primary and metastatic central nervous system tumors.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. Chai, X. Lu, V. Godfrey, C. Fletcher, C. W.M. Roberts, T. Van Dyke, and B. E. Weissman
Tumor-Specific Cooperation of Retinoblastoma Protein Family and Snf5 Inactivation
Cancer Res., April 1, 2007; 67(7): 3002 - 3009.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
T. L. Pauls, F. Portis, E. Macrì, B. Belser, P. Heitz, C. Doglioni, and M. R. Celio
Parvalbumin Is Expressed in Normal and Pathological Human Parathyroid Glands
J. Histochem. Cytochem., January 1, 2000; 48(1): 105 - 112.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.